Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 19.05% vs 18.73% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 35.53% vs 96.09% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 6.93% vs -0.38% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 56.93% vs 603.82% in Mar 2024
Compare Profit and Loss Results of Goldline Pharmac
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
28.00
67.00
-39.00
-58.21%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
28.00
67.00
-39.00
-58.21%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-1.00
1.00
100.00%
Raw Materials Consumed
10.00
33.00
-23.00
-69.70%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
5.00
10.00
-5.00
-50.00%
Operating Expenses
0.00
6.00
-6.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
4.00
7.00
-3.00
-42.86%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
22.00
64.00
-42.00
-65.62%
Operating Profit (PBDIT) excl Other Income
5.00
2.00
3.00
150.00%
Other Income
0.00
0.00
0.00
0%
Operating Profit (PBDIT)
5.00
2.00
3.00
150.00%
Interest
1.00
0.00
1.00
0%
Profit before Depriciation and Tax
4.00
2.00
2.00
100.00%
Depreciation
0.00
0.00
0.00
0%
Profit Before Taxation & Exceptional Items
3.00
2.00
1.00
50.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
3.00
2.00
1.00
50.00%
Provision for Tax
1.00
0.00
1.00
0%
Profit After Tax
2.00
1.00
1.00
100.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
3.00
8.00
-5.00
-62.50%
Profit Available for appropriations
6.00
10.00
-4.00
-40.00%
Appropriations
6.00
10.00
-4.00
-40.00%
Equity Dividend (%)
0%
8%
-8.00
Earnings Per Share
4.11
1.6
2.51
156.88%
Profit And Loss - Net Sales
Net Sales 28.06 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 19.05% vs 18.73% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.83 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 35.53% vs 96.09% in Mar 2024
Profit And Loss - Interest
Interest 1.72 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 6.93% vs -0.38% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 2.83 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 56.93% vs 603.82% in Mar 2024
